Bryan Smith

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study

Rocío Lledó‐García, Shikiko Watanabe, Grant Langdon et al. · Science Translational Medicine · 2017 · 195 citations

Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia

Harald Noedl, Youry Se, Sabaithip Sriwichai et al. · Clinical Infectious Diseases · 2010 · 194 citations

Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer

Charlene Porter, Sylvia Armstrong‐Fisher, Tim Kopotsha et al. · Journal of Reproductive Immunology · 2016 · 111 citations · Full text

Vitro Transcytosis, Laboratory Immunology, Immunology +25

Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration

Bryan Smith, Rocío Lledó‐García, Kate L. Dixon et al. · mAbs · 2018 · 110 citations · Full text

Immunocytochemical Technique, Immunotoxicology, Antibody Isolation +18

Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis

Jeffrey T. Guptill, Vern C. Juel, Janice M. Massey et al. · Autoimmunity · 2016 · 107 citations · Full text